OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ATCK.KW55

Advanced Technology Co KSCP

Medical Equipment, Supplies & DistributionVerified

The company’s capital structure is highly leveraged, with a debt-to-equity ratio of 2.77, indicating significant reliance on debt financing. Despite holding KWD 7.34 million in cash and equivalents, the firm’s long-term debt of KWD 199.34 million suggests a liquidity risk, as net cash is negative after subtracting total debt. Free cash flow is negative at KWD 9,300, and capital expenditures of KWD 2.14 million were made in the period, further straining liquidity. Profitability metrics are weak, with a return on equity of 0.08% and a return on assets of 0.02%, both far below typical thresholds for healthy performance in the medical equipment and distribution industry. Operating income of KWD 2.25 million and net income of KWD 58,940 suggest minimal profitability, with a gross margin of 26.57% (KWD 10.88 million gross profit on KWD 40.94 million revenue) that is likely insufficient to cover operating and financial costs. Geographic and segment exposure is not explicitly detailed in the available data, but the firm operates as a single entity within the medical equipment and distribution industry. Revenue concentration is not disclosed, but the absence of segment reporting implies a lack of diversification. Growth appears stagnant, with no clear trajectory provided in the outlook. The firm’s operating cash flow of KWD 9.54 million is modest and does not support significant reinvestment or expansion. The lack of positive revenue growth or margin expansion in the financials suggests limited near-term upside. Risk factors include high leverage and weak profitability, with a debt-to-equity ratio of 2.77 and a current ratio of 1.32, both signaling liquidity and solvency concerns. Dilution risk is assessed as low, with no difference between basic and diluted shares outstanding, and no recent equity issuance disclosed. Recent events or filings are not detailed in the available data, but the firm’s financials suggest a need for operational or strategic adjustments to improve profitability and reduce debt exposure.

30-day price · ATCK.KW+6.00 (+1.1%)
Low$528.00High$695.00Close$576.00As of17 May, 00:00 UTC
Profile
CompanyAdvanced Technology Co KSCP
TickerATCK.KW
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Advanced Technology Co KSCP provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products and services.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

The company’s capital structure is highly leveraged, with a debt-to-equity ratio of 2.77, indicating significant reliance on debt financing. Despite holding KWD 7.34 million in cash and equivalents, the firm’s long-term debt of KWD 199.34 million suggests a liquidity risk, as net cash is negative after subtracting total debt. Free cash flow is negative at KWD 9,300, and capital expenditures of KWD 2.14 million were made in the period, further straining liquidity. Profitability metrics are weak, with a return on equity of 0.08% and a return on assets of 0.02%, both far below typical thresholds for healthy performance in the medical equipment and distribution industry. Operating income of KWD 2.25 million and net income of KWD 58,940 suggest minimal profitability, with a gross margin of 26.57% (KWD 10.88 million gross profit on KWD 40.94 million revenue) that is likely insufficient to cover operating and financial costs. Geographic and segment exposure is not explicitly detailed in the available data, but the firm operates as a single entity within the medical equipment and distribution industry. Revenue concentration is not disclosed, but the absence of segment reporting implies a lack of diversification. Growth appears stagnant, with no clear trajectory provided in the outlook. The firm’s operating cash flow of KWD 9.54 million is modest and does not support significant reinvestment or expansion. The lack of positive revenue growth or margin expansion in the financials suggests limited near-term upside. Risk factors include high leverage and weak profitability, with a debt-to-equity ratio of 2.77 and a current ratio of 1.32, both signaling liquidity and solvency concerns. Dilution risk is assessed as low, with no difference between basic and diluted shares outstanding, and no recent equity issuance disclosed. Recent events or filings are not detailed in the available data, but the firm’s financials suggest a need for operational or strategic adjustments to improve profitability and reduce debt exposure.
Key takeaways
  • The company is highly leveraged, with a debt-to-equity ratio of 2.77, indicating significant financial risk.
  • Profitability is weak, with a return on equity of 0.08% and a return on assets of 0.02%.
  • Free cash flow is negative, and capital expenditures are not being offset by operating cash flow.
  • The firm lacks segment or geographic diversification, as no such details are disclosed.
  • Liquidity is a concern, with net cash negative after subtracting total debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKWD
Revenue$40.9M
Gross profit$10.9M
Operating income$2.2M
Net income$58.9k
R&D
SG&A
D&A
SBC
Operating cash flow$9.5M
CapEx-$2.1M
Free cash flow-$9.3k
Total assets$339.5M
Total liabilities$267.7M
Total equity$71.9M
Cash & equivalents$7.3M
Long-term debt$199.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$142.3M$10.9M$5.3M$5.1M
FY-3$165.5M$13.9M$7.0M$8.1M
FY-2$168.6M$12.9M$5.0M-$1.2M
FY-1$179.2M$10.0M$703.9k-$2.1M
FY0$160.4M-$11.0M-$16.2M-$15.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$321.3M$63.8M$3.1M
FY-3$307.8M$69.4M$2.3M
FY-2$347.0M$71.8M$3.1M
FY-1$344.4M$70.4M$2.4M
FY0$320.5M$53.1M$4.6M
PeriodOCFCapExFCFSBC
FY-4$4.7M-$6.2M$5.1M
FY-3$37.4M-$4.0M$8.1M
FY-2$34.6M-$10.8M-$1.2M
FY-1$4.7M-$7.4M-$2.1M
FY0$25.4M-$6.4M-$15.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$40.9M$2.2M$58.9k-$9.3k
FQ-6$46.5M$2.9M$831.1k-$827.4k
FQ-5$49.8M$3.3M$681.5k$1.4M
FQ-4$42.0M$1.6M-$867.6k-$2.6M
FQ-3$33.8M-$668.8k-$2.6M-$2.6M
FQ-2$46.4M$842.1k-$975.6k-$632.0k
FQ-1$40.3M$938.8k-$972.5k-$896.0k
FQ0$39.9M-$12.1M-$11.7M-$11.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$339.5M$71.9M$7.3M
FQ-6$342.5M$69.7M$2.4M
FQ-5$356.2M$70.4M$4.7M
FQ-4$344.4M$70.4M$2.4M
FQ-3$341.2M$67.9M$6.1M
FQ-2$335.5M$66.8M$3.2M
FQ-1$334.6M$65.4M$3.9M
FQ0$320.5M$53.1M$4.6M
PeriodOCFCapExFCFSBC
FQ-7$9.5M-$2.1M-$9.3k
FQ-6$7.2M-$2.8M-$827.4k
FQ-5$2.1M-$4.4M$1.4M
FQ-4$4.7M-$7.4M-$2.6M
FQ-3$6.9M-$1.9M-$2.6M
FQ-2$16.4M-$3.4M-$632.0k
FQ-1$17.9M-$5.2M-$896.0k
FQ0$25.4M-$6.4M-$11.2M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$71.9M
Net cash-$192.0M
Current ratio1.3
Debt/Equity2.8
ROA0.0%
ROE0.1%
Cash conversion161.9%
CapEx/Revenue-5.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricATCK.KWActivity
Op margin5.5%3.9% medp25 -31.3% · p75 14.4%above median
Net margin0.1%2.4% medp25 -30.5% · p75 11.1%below median
Gross margin26.6%46.7% medp25 28.2% · p75 63.1%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-5.2%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity277.0%17.9% medp25 2.7% · p75 52.2%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 03:06 UTC#3506358a
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:05 UTCJob: 99943628